Cagrilintide
Cagrilintide 10 mg
Many researchers stack Retatrutide with Cagrilintide for synergistic metabolic research.
Cagrilintide is an investigational, long-acting acylated analog of the pancreatic hormone amylin, developed as a powerful tool for biochemical research into metabolic regulation. As a non-selective dual agonist, it activates both amylin (AMYR) and calcitonin (CTR) receptors. Its molecular structure features a C20 fatty diacid modification that significantly prolongs its biological half-life compared to native amylin. In in vitro and preclinical animal studies, cagrilintide has demonstrated strong effects on satiety signaling and delayed gastric emptying, making it a valuable research compound for exploring advanced peptide-based pathways in appetite control, energy balance, and metabolic function.
This compound is offered strictly for research use only (RUO)
No description available.
Additional information
| Weight | 0.2 lbs |
|---|
Available Certificates
-
BWC-1457978 - Cagrilintide - 10